STOCK TITAN

Electromed, Inc. Schedules its Third Quarter Fiscal 2022 Financial Results Conference Call for May 10, 2022 at 5:00 p.m. ET

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Electromed, Inc. (AMEX: ELMD) announced its financial results for the fiscal 2022 third quarter, ending March 31, 2022, will be released on May 10, 2022, after market close. A conference call to discuss these results will follow at 5:00 p.m. Eastern Time on the same day. Participants can join by dialing specific numbers provided in the release. For those unable to attend, a replay will be available via phone and online.

Positive
  • None.
Negative
  • None.

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 third quarter ended March 31, 2022, on Tuesday, May 10, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International), and using pin number 13729193.

The live conference call webcast will be accessible in the Investor Relations section of Electromed’s web site and directly via the following link: https://services.choruscall.com/mediaframe/webcast.html?webcastid=n0KYeYTK

For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Domestic) or (412) 317-6671 (International) and referencing the replay pin number 13729193. Additionally, an online replay will be available in the Investor Relations section of Electromed’s web site at: http://investors.smartvest.com/.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about the Company can be found at www.smartvest.com.

Mike MacCourt, Chief Financial Officer

(952) 758-9299

investorrelations@electromed.com



Mike Cavanaugh, Investor Relations

ICR Westwicke

(617) 877-9641

mike.cavanaugh@westwicke.com

Source: Electromed, Inc.

FAQ

When will Electromed, Inc. announce its Q3 2022 financial results?

Electromed, Inc. will announce its Q3 2022 financial results on May 10, 2022, after market close.

What time is the Electromed conference call scheduled for?

The conference call to discuss the financial results is scheduled for May 10, 2022, at 5:00 p.m. Eastern Time.

How can I participate in Electromed's conference call?

You can participate by dialing (877) 407-0789 for domestic calls or (201) 689-8562 for international calls, using pin number 13729193.

Where can I find the replay of the Electromed conference call?

The replay will be available by dialing specific phone numbers provided in the press release and also accessible online in the Investor Relations section of Electromed's website.

What products does Electromed, Inc. offer?

Electromed, Inc. manufactures products for airway clearance therapy, including the SmartVest® Airway Clearance System.

Electromed, Inc.

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Stock Data

253.39M
6.69M
27.77%
36.07%
1.73%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
NEW PRAGUE